Finance
Company reports 17.7% sales increase in the first quarter
Published in AIDS Weekly, June 24th, 2002
The company also announced that it had submitted U.S. and European regulatory packages to the FDA and EMEA to seek regulatory approvals for D2E7, its anti-TNF agent for rheumatoid arthritis, and that it had been awarded an exclusive, multiyear contract to supply the American Red Cross with six infectious disease tests used to screen blood.
Worldwide sales for the first quarter were $4.189 billion, up 17.7% from $3.560 billion in the first quarter of 2001. Earnings per share for the quarter were 54 cents, meeting the First Call analyst consensus...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2002-06-24)
More Articles from AIDS Weekly
- AIDS and HIV Therapy
DC-SIGN could be therapeutic target - Antiviral Cleansing
Plasma treatment appears to be cause of hyperfibrinolysis in transplant recipients - AIDS and HIV Dementia
Cell cycle protein expression altered during HIV encephalitis - AIDS and HIV Therapy
Attenuated infection can create powerful antiviral T cells - AIDS and HIV Therapy
HIV repressor factor linked to viral quiescence - AIDS and HIV Therapy
RNA splicing regulators can be used to modulate viral protein function - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
